http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5114964-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58833d6c0dc5cfab5bbd7e8354619752 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 |
filingDate | 1990-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1992-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ca3e6da5228e4d15a884150449e467b |
publicationDate | 1992-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-5114964-A |
titleOfInvention | Aryl-substituted benzocycloalkyl-derived anti-atherosclerotic agents |
abstract | Disclosed are novel aryl-substituted benzocycloalkyl-derived 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula: ##STR1## their corresponding dihydroxy acids, and pharmaceutically acceptable salts thereof. |
priorityDate | 1989-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 212.